High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$24.6M
$24,570,827
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
OLMA
M
Olema Pharmaceuticals, Inc.
Mitchell Shawnte
• Officer • CHIEF LEGAL OFFICER
Other
2026-03-04
$109,250
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CHIEF LEGAL OFFICER
Other
|
2026-03-04 | $109,250 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Mitchell Shawnte
• Officer • CHIEF LEGAL OFFICER
Discretionary SellΔOwn -99.1%
2026-03-04
$606,353x2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CHIEF LEGAL OFFICER
Discretionary SellΔOwn -99.1%
|
2026-03-04 | $606,353x2 | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Mitchell Shawnte
• Officer • CHIEF LEGAL OFFICER
Other
2026-03-03
$65,550
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CHIEF LEGAL OFFICER
Other
|
2026-03-03 | $65,550 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Mitchell Shawnte
• Officer • CHIEF LEGAL OFFICER
Discretionary Sell
2026-03-03
$345,150
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CHIEF LEGAL OFFICER
Discretionary Sell
|
2026-03-03 | $345,150 | S | Form 4 |
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Discretionary Sell
|
2026-01-20 | $268,800 | S | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Kovacs Shane William Charles
• Officer • CH. OPERATING & FINANCIAL OFF.
Discretionary SellΔOwn -41.7%
2026-01-15
$2,873,000Large
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. OPERATING & FINANCIAL OFF.
Discretionary SellΔOwn -41.7%
|
2026-01-15 | $2,873,000Large | S | Form 4 |
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Discretionary Sell
|
2026-01-14 | $101,600 | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Other
2026-01-14
$243,500
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Other
|
2026-01-14 | $243,500 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
2026-01-14
$1,443,651Largex2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
|
2026-01-14 | $1,443,651Largex2 | S | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Kovacs Shane William Charles
• Officer • CH. OPERATING & FINANCIAL OFF.
Discretionary Sell
2026-01-13
$107,054
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. OPERATING & FINANCIAL OFF.
Discretionary Sell
|
2026-01-13 | $107,054 | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Other
2026-01-13
$243,500
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Other
|
2026-01-13 | $243,500 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
2026-01-13
$1,380,178Largex2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
|
2026-01-13 | $1,380,178Largex2 | S | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
2026-01-12
$283,400
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
|
2026-01-12 | $283,400 | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Equity Compensation
2025-12-23
$351,000x2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-23 | $351,000x2 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Discretionary SellΔOwn -95.7%
2025-12-23
$2,752,419Large
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Discretionary SellΔOwn -95.7%
|
2025-12-23 | $2,752,419Large | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Equity Compensation
2025-12-22
$703,392x4
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-22 | $703,392x4 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Discretionary SellΔOwn -64.9%
2025-12-22
$2,804,000Large
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Discretionary SellΔOwn -64.9%
|
2025-12-22 | $2,804,000Large | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
CLARK IAN T
• Director
Equity Compensation
2025-12-19
$1,219,544Largex7
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Equity Compensation
|
2025-12-19 | $1,219,544Largex7 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
CLARK IAN T
• Director
Discretionary SellΔOwn -11.3%
2025-12-19
$7,873,109Whalex3
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Discretionary SellΔOwn -11.3%
|
2025-12-19 | $7,873,109Whalex3 | S | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
2025-12-19
$1,553,544Largex3
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
|
2025-12-19 | $1,553,544Largex3 | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Equity Compensation
2025-12-19
$610,000x2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-19 | $610,000x2 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Discretionary SellΔOwn -11.1%
2025-12-19
$1,973,729Largex2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Discretionary SellΔOwn -11.1%
|
2025-12-19 | $1,973,729Largex2 | S | Form 4 |
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Other
|
2025-11-21 | $13,989 | M | Form 4 |
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Discretionary Sell
|
2025-09-18 | $108,976x2 | S | Form 4 |
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Discretionary Sell
|
2025-09-16 | $95,865x2 | S | Form 4 |